Seeking Alpha

Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock...

Alexion Pharmaceuticals (ALXN -1.2%) says its Board of Directors has authorized a $400M stock buyback. The Board's authorization is open-ended and doesn't establish a timeframe for the purchases, and the company expects to fund all repurchases from cash on hand and future cash flows from operations.
From other sites
Comments (1)
  • ThLizrd
    , contributor
    Comment (1) | Send Message
     
    "Net present value of expected future cash flows" on SALE now at Alexion! ---thlizrd
    9 Nov 2012, 06:05 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs